Fujian, China

Huihuang Lin

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biosteed Gene Expression Tech. Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huihuang Lin. Retrieved from https://idiyas.com/inventor/huihuang-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huihuang Lin: Innovator in Growth Hormone Modification

Introduction

Huihuang Lin is a notable inventor based in Fujian, China. He has made significant contributions to the field of biotechnology, particularly in the modification of growth hormones. His innovative work focuses on enhancing the biological activity of growth hormones through advanced chemical techniques.

Latest Patents

Huihuang Lin holds a patent for a "Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof." This invention involves a growth hormone that has been modified with double-stranded polyethylene glycol at a single site. The PEGylated growth hormone exhibits higher biological activity and a longer half-life compared to unmodified growth hormones. This composition is particularly useful in treating growth or development disorders, such as growth hormone deficiency and Turner syndrome.

Career Highlights

Huihuang Lin is associated with Biosteed Gene Expression Tech Co., Ltd., where he applies his expertise in biotechnology. His work has been instrumental in advancing the understanding and application of modified growth hormones in medical treatments.

Collaborations

Huihuang Lin collaborates with esteemed colleagues, including Weidong Zhou and Ping Zhang, who contribute to his research and development efforts in the field of biotechnology.

Conclusion

Huihuang Lin's innovative work in the modification of growth hormones represents a significant advancement in biotechnology. His contributions have the potential to improve treatments for various growth disorders, showcasing the importance of innovation in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…